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KlADH4 is a gene of Kluyveromyces lactis encoding a mitochondrial alcohol dehydrogenase activity which is
specifically induced by ethanol. The promoter of this gene was used for the expression of heterologous proteins
in K. lactis, a very promising organism which can be used as an alternative host to Saccharomyces cerevisiae due
to its good secretory properties. In this paper we report the ethanol-driven expression in K. lactis of the
bacterial b-glucuronidase and of the human serum albumin (HSA) genes under the control of the KlADH4
promoter. In particular, we studied the extracellular production of recombinant HSA (rHSA) with integrative
and replicative vectors and obtained a significant increase in the amount of the protein with multicopy vectors,
showing that no limitation of KlADH4 trans-acting factors occurred in the cells. By deletion analysis of the
promoter, we identified an element (UASE) which is sufficient for the induction of KlADH4 by ethanol and,
when inserted in the respective promoters, allows ethanol-dependent activation of other yeast genes, such as
PGK and LAC4. We also analyzed the effect of medium composition on cell growth and protein secretion. A
clear improvement in the production of the recombinant protein was achieved by shifting from batch cultures
(0.3 g/liter) to fed-batch cultures (1 g/liter) with ethanol as the preferred carbon source.
Kluyveromyces lactis is an aerobic yeast which is able to grow
on lactose as the sole carbon source. Due to this property,
which is rare among yeasts, K. lactis has been used for the
purification of the enzyme lactase (b-galactosidase) and for the
production of low-lactose milk in the dairy industry (22), and
the conditions used for cultivation of this organism on the large
scale have been well established. In the last few years, K. lactis
has been successfully used as an alternative host to Saccharo-
myces cerevisiae for heterologous gene expression, and good
transformation systems and stable multicopy vectors are now
available for the genetic manipulation of this yeast (for re-
views, see references 16, 32, and 44). Expression of heterolo-
gous genes in K. lactis can be achieved by the use of constitu-
tive promoters which have also been isolated in S. cerevisiae;
such promoters are interchangeable between the two yeasts.
However, S. cerevisiae inducible promoters are not always
tightly regulated in K. lactis cells, suggesting the existence of
different regulatory circuits on gene expression in the two
organisms.
Regulated promoters have been obtained from the K. lactis
genes lactase (LAC4) (18, 26, 33, 46) and acid phosphatase
(KlPHO5) (14, 15). These genes are regulated in a very similar
way to the corresponding GAL and PHO5 genes of S. cerevi-
siae, which are induced at the transcriptional level in the pres-
ence of lactose or galactose and of low phosphate concentra-
tions, respectively (40, 45).
KlADH4 is a K. lactis gene induced by ethanol, encoding a
mitochondrial alcohol dehydrogenase (ADH) activity with in-
teresting regulatory properties (35). Such regulation can be
observed in Rag2 (resistance to antibiotics on glucose) strains
of K. lactis, which are unable to grow on glucose in the pres-
ence of mitochondrial inhibitors (19). In these strains, which
are impaired in sugar fermentation and are poor producers of
ethanol, the addition of ethanol specifically induced KlADH4
while the addition of glycerol and other nonfermentable car-
bon sources did not induce the expression of this gene. More-
over, differently from the ADH2 gene of S. cerevisiae (8–10),
the induction of KlADH4 is not sensitive to glucose repression,
since the gene is expressed when both glucose and ethanol are
present in the culture medium (29, 34).
All these findings suggested to us the possibility of using the
promoter regions of KlADH4 for ethanol-dependent expres-
sion of heterologous genes in K. lactis Rag2 strains. Such
strains can be either naturally isolated or constructed in the
laboratory by disrupting genes which affect the glycolytic flux,
such as KlPGI1 (29), the gene encoding phosphoglucoisomer-
ase, or genes directly involved in ethanol production, such as
KlPDC1, the gene encoding pyruvate decarboxylase of K. lactis
(3). By contrast, in Rag1 strains, the KlADH4 promoter is also
active in cells growing in glucose and other fermentable carbon
sources because of the ethanol produced by cells through fer-
mentation, but its transcriptional activity can be still increased
(two- to threefold) by the addition of exogenous ethanol (data
not shown).
In this paper, we report the isolation of the KlADH4 pro-
moter and its use for the regulated expression of bacterial and
human genes. We also identified a small region of the pro-
moter which is responsible for the induction of the gene in the
presence of ethanol.
In K. lactis cells, an efficient production of heterologous
proteins with enzymatic activity, such as prochymosine (46)
and a-galactosidase (1), and proteins of therapeutic interest,
such as interleukin-1b (4, 17), hepatitis B surface antigen (28),
granulocyte colony-stimulating factor (21), and human serum
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albumin (HSA) (5, 18), have been efficiently produced (for a
review, see reference 44).
To optimize the production of recombinant HSA (rHSA)
under the control of the KlADH4 promoter, we focused on the
medium composition and growth conditions; in preliminary
attempts, we obtained good yields of rHSA in fed-batch fer-
mentation.
MATERIALS AND METHODS
Strains. The following K. lactis strains were used in this work. MW98-8C (a
uraA lys arg rag1 pgi1 adh3) is the parental strain (2). MS1 is a derivative of
MW98-8C carrying an integrated copy of plasmid P4GUS into the KlADH4
chromosomal locus (12) CMK5 (a thr lys pgi1 adh3 adh1::URA3 adh2::URA3),
which expresses only KlADH4, was obtained by crossing strains that lacked single
ADH activities (29). CBS 293.91 is a prototrophic natural K. lactis isolate (12).
Y 721 is an isogenic derivative of CBS 293.91 carrying a disrupted copy of the
phosphoglycerate kinase (PGK) gene (12). This strain, used for many genera-
tions in batch and fed-batch fermentations, showed a Rag1 phenotype for the
presence of the PGK gene on plasmid pYG156. Since the gene is essential for the
growth on fermentable carbon sources, such a host-vector combination resulted
in the stabilization of the expression system.
Media and culture conditions. YPD consists of (grams/liter) glucose, 20; yeast
extract (Difco), 10; and Bacto Peptone (Difco), 20; supplemented, when re-
quired, with 100 mg of Geneticin G418 (Sigma) per liter. When indicated,
ethanol (YPE), glycerol (YPG), or glucose plus ethanol (YPDE) at 20, 30, and
20 1 10 g/liter, respectively, were added instead of glucose.
M9YE consists of (grams/liter) carbon substrate, 20; yeast extract, 10;
Na2HPO4, 6; KH2PO4, 3; NaCl, 0.5, NH4Cl, 1; CaCl2 z 2H2O, 0.015; and MgSO4 z
7H2O, 0.24.
DM1 (defined medium 1) consists of (grams/liter) carbon substrate, 20;
Na2HPO4, 4.4; KH2PO4, 4; MgSO4 z 7H2O, 0.5; CaCl2 z 2H2O, 0.1; sodium
glutamate, 3; and ammonium acetate, 7; 1 ml of salt solution (13 mg of FeSO4 z
7H2O per ml, 9 mg of MnSO4 z H2O per ml, 1.8 mg of CoCl2 z 6H2O per ml, 18
mg of ZnSO4 z 7H2O per ml, 0.9 mg of AlCl3 z 6H2O per ml, 0.22 mg of CuCl2 z
2H2O per ml) per liter, and 1 ml of vitamin solution (13.5 mg of niacin per ml,
0.036 mg of biotin per ml, 1.8 mg of calcium pantothenate per ml, 2 mg of
m-inositol per ml) per liter.
Shake flask cultures. Flasks (300 ml) containing 50 ml of medium were seeded
with 0.5 ml of an inoculum grown to the stationary phase on the same medium.
Cultures were grown for 3 days at 28°C on a rotary shaker (220 rpm) for rHSA
production.
Fed-batch cultures. Fermentations were carried out in a 2-liter fermentor
(SETRIC France) containing 0.8 liter of medium. The fermentor was inoculated
with 40 ml of a fresh preculture grown to the stationary phase on the same
medium. During fermentation, the pH was automatically controlled and adjusted
between 6.5 and 7.0 with 10% (wt/vol) ammonia and the temperature was
maintained at 28°C. Aeration was maintained at 75 liters/h under 0.2 3 105 Pa,
and the dissolved oxygen was controlled at ;30% air saturation by the impeller
speed controller and, when necessary, by enrichment of the air stream with pure
O2. All the process variables (pH, temperature, agitation, dissolved oxygen, and
O2 and CO2 contents in the exhaust gases) were transduced on-line and inter-
faced by a PH3852 unit to a Hewlett-Packard 9000 computer. The compositions
of the feed media were carbon source, 340 g/liter; yeast extract, 100 g/liter;
ammonium acetate, 50 g/liter; or carbon source, 340 g/liter; sodium glutamate, 40
g/liter; ammonium acetate, 70 g/liter; and vitamins for complex and defined
media, respectively.
General methods. Restriction enzyme digestions, plasmid engineering, and
standard techniques were performed as specified by Sambrook et al. (37). Esch-
erichia coli and yeast transformation was performed by electroporation with a
Bio-Rad Gene-Pulser apparatus as specified by the manufacturer.
PCR amplification and cloning of KlADH4 promoter fragments. The oligonu-
cleotides used in PCR amplifications are listed in Table 1. PCRs were performed
with the GeneAmp kit (Perkin-Elmer Cetus), using as template a 4.0-kbp
genomic DNA region of K. lactis, which contained the KlADH4 gene, cloned on
a plasmid. The reaction mixture (100 ml) contained 0.2 mM each primer, 0.2 mM
each deoxynucleoside triphosphate, 13 PCR buffer, 25 ng of DNA, 2 mM
MgCl2, and 2.5 U of Ampli-Taq DNA polymerase. PCR was carried out for 30
cycles of 94°C for 1 min, 52°C for 2 min, and 72°C for 3 min. After amplification,
the DNA fragments were purified on agarose gels, digested with the appropriate
enzyme, cloned into the pKSII plasmid (Stratagene cloning system), and trans-
ferred to K. lactis replicating plasmids by standard procedures.
Vector constructions. E. coli b-glucuronidase (GUS) and HSA expression
vectors pP4-GUS, pYG132, and pYG156 (Fig. 1) were engineered as derivatives
of pKD1, a natural plasmid originally isolated from Kluyveromyces drosophilarum
(7, 13). pKD1 is structurally related to the S. cerevisiae plasmid 2mm and can
stably replicate in K. lactis (2).
The details of the construction of pP4-GUS and pYG132 were described
previously (12). Briefly, pP4-GUS is a vector derived from vector pSK-Kan401,
which contains the pKD1 origin of replication (6). The GUS gene was isolated
from plasmid pBI221 (Clontech) as a BamHI-EcoRI fragment, 2.1 kb in length,
and placed under control of the KlADH4 BglII-BamHI portable promoter. The
resulting expression cassette was introduced as a BglII-EcoRI fragment into the
BamHI and EcoRI sites of pSK-Kan401. The stability of plasmid pYG132,
measured as the percentage of G418-resistant colonies, was 100% after 200
generations.
Construction of KlADH4 promoter-HSA fusion vectors. In contrast to pP4-
GUS, plasmid pYG132 contains the entire sequence of pKD1, linearized at the
unique EcoRI site, as well as an HSA expression cassette consisting of the
KlADH4 SalI-HindIII portable promoter, the prepro-HSA cDNA gene, and the
S. cerevisiae phosphoglycerate kinase (PGK) terminator. pYG156 contains the
entire pKD1 and the K. lactis PGK gene that can be used as a selectable marker
in pgk mutant host strains (12). The common features of all three vectors are the
presence of the E. coli origin of replication, allowing the plasmids to work as
shuttle vectors, and the presence of the bla and aph genes conferring ampicillin
and geneticin resistance to E. coli and yeast, respectively. In addition, pP4-GUS
carries the S. cerevisiae URA3 gene as an auxotrophic marker.
The vectors pYG107 and pYG108 contain the entire pKD1 sequence and the
HSA cDNA fused to LAC4 and PGK promoters, respectively (18).
To construct pYG534 and pYG397, the region from 2536 to 213 was ob-
tained by PCR amplification with oligonucleotides 5 and 8, and the region from
2399 to 213 was obtained with oligonucleotides 7S and 8. After SalI-HindIII
digestion, these fragments were inserted into plasmid pYG108 to give pYG534
and pYG397, respectively.
To construct pYG108/700M and pYG108DUAS, the region from 21199 to
2519 was obtained by PCR amplification with oligonucleotides 1 and 6. This
SalI-HindIII fragment was cloned into the polylinker of pKSII plasmid. The
HindIII site was eliminated by filling in with Klenow polymerase to give plasmid
pKSII/700M. The 700-bp fragment was cut by a SalI-NotI digestion and cloned
into plasmid pYG108 to give plasmid pYG108/700M. In plasmid pYG108/700M,
the region of the PGK promoter from 21499 to 2402 containing the upstream
activation site (UAS) was replaced by the 700-bp fragment of the KlADH4
promoter. As a control, the pYG108 plasmid was digested with SalI-NotI, filled
in with Klenow DNA polymerase, and religated with DNA T4 ligase. The re-
sulting plasmid was called pYG108DUAS.
Plasmid pYG108/2-4 contains the promoter regions from 2953 to 2741 (am-
plified with oligonucleotides 2 and 4) cloned into the SalI-EcoRI sites of plasmid
pYG108/700M.
Plasmid pCM13 carries the region of the KlADH4 promoter spanning from
2399 to 213 (amplified with oligonucleotides 7E and 8). The amplified fragment
was inserted into the EcoRI-HindIII sites of plasmid pYG108/700M. In this way,
the PGK promoter TATA box was replaced with the KlADH4 TATA box.
Plasmid pCM15 was obtained by cloning the promoter fragment contained in
plasmids pYG108/2-4 into the SalI-EcoRI sites of pCM13. The promoter regions
from 2758 to 2519 (amplified with oligonucleotides 3 and 6) were cloned in the
SalI-HindIII sites of the pKSII polylinker to yield plasmid pKS/3-6. After SalI-
EcoRI digestion, the promoter fragment was cloned into pCM13 plasmid to yield
plasmid pCM16.
In pCM17, two of the three UAS elements contained in the LAC4 promoter
were replaced with the 200-bp fragment containing UASE.
Protein assays. Cultures (10 ml) of K. lactis were grown to the early stationary
phase in YP medium containing different carbon sources as specified in the text.
TABLE 1. Nucleotide sequence of the oligonucleotides used in
PCR amplification of different regions of the KlADH4 promoter
Nucleotide sequencea
21197 21179
1 ............................(SalI) ccccg/tcgacCGGCTACTAATAGAAGTTC
2936 2953
2 ............................(SalI) cgcgg/tcgacGGAACGACGGTACATAAG
2758 2741
3 ............................(SalI) ccccg/tcgacCGGCGCCTGAAATTTTCC
2741 2758
4 ............................(EcoRI) cgcgg/aattcGGAAAATTTCAGGCGCCG
2536 2519
5 ............................(SalI) ccccg/tcgacCCAGAAGTCGGAGTTTAC
2519 2536
6 ............................(HindIII) cgcga/agcttGTAAACTCCGACTTCTGG
2400 2383
7S..........................(SalI) ccccg/tcgacGTGTGTGCTGTGCCTTCC
2400 2383
7E .........................(EcoRI) cgcgg/aattcGTGTGTGCTGTGCCTTCC
213 230
8 ............................(HindIII) cgcga/agcttATGTTGTGTTGTTGGTGG
a Chromosomal sequences of K. lactis are in capital letters.
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The cells were broken with glass beads in Eppendorf tubes and centrifuged, and
the supernatants were analyzed by electrophoresis on 5% nondenaturing acryl-
amide minigels. Gel preparation and buffers were essentially as described by
Williamson et al., (47). Samples corresponding to 20 to 40 mg of proteins were
run at 4°C for 60 min at 20 mA. For the detection of ADH activity, the gels were
stained as described by Lutstorf and Megnet (27). GUS activity (39) was detected
by soaking the gels in a staining solution containing 50 mM Na2HPO4 (pH 7.0)
and 50 mg of 5-bromo-4-chloro-3-indolyl glucuronide (X-Glu) per ml dissolved in
dimethylformamide (5 mg/ml). The gels were then incubated at 37°C until bands
corresponding to the enzymatic activities became visibly stained.
Albumin detection. To detect albumin, 5 3 105 cells/ml were inoculated into
YPD or YPDE medium and supernatants were tested after 3 days of fermenta-
tion. Aliquots of the supernatants were electrophoresed on sodium dodecyl
sulfate-polyacrylamide gels, and the protein was revealed by Coomassie brilliant
blue staining or by Western blotting. When the latter method was used, aliquots
of supernatants were separated on sodium dodecyl sulfate–10% polyacrylamide
gels and proteins were electroblotted onto Immobilon P membranes (Millipore)
with a Bio-Rad wet blotting system. Filters were saturated by incubation for 30
min at room temperature in phosphate-buffered saline (PBS) with 5% nonfat dry
milk. The blots were washed twice in PBST (PBS, 0.05% Tween 20) and incu-
bated for 2 h with the anti-HSA monoclonal antibody (Sigma Co.A-0433) diluted
1:16,000 in PBS. After two washes with PBST, the filters were incubated for 1 h
with the secondary antibody linked to the alkaline phosphatase. After two final
washes, the blots were developed with the 5-bromo-4-chloro-3-indolyl phos-
phate–nitroblue tetrazolium system (20).
RESULTS
Cloning of the K. lactis KlADH4 promoter. The KlADH4
gene was isolated as an 8.4-kb BamHI fragment from a K. lactis
genomic bank by using an S. cerevisiae ADH2-derived probe
(36). Based on the nucleotide sequence of the KlADH4 coding
region (35), we located the ATG initiation codon close to a
HindIII site. Accordingly, we subcloned a 2.2-kb HindIII frag-
ment containing the KlADH4 upstream region and the first 14
codons of the coding region into plasmid pTZ19 (Pharmacia).
This construct was used to introduce a BamHI site 10 nucle-
otides upstream from the ATG codon by site-direct mutagen-
esis by using the double-primer procedures (37). The resulting
plasmid allowed the isolation of a 1.2-kb BglII-BamHI portable
promoter used in the construction of the pP4-GUS expression
vector (Fig. 1). A promoter variant in which the BglII and
BamHI sites were replaced by SalI and HindIII sites, respec-
tively, was obtained by the PCR procedure (pBluescript, mung
bean nuclease). This variant was used in the engineering of
albumin expression vectors pYG132 and pYG156 (Fig. 1).
Ethanol-regulated expression of bacterial GUS. We then
wondered whether the KlADH4 promoter could be successfully
used for the regulated expression of heterologous genes. First
we used the E. coli GUS gene as a reporter gene under control
of the KlADH4 upstream region (see Materials and Methods).
The resulting plasmid, named pP4-GUS (Fig. 1), was used to
transform K. lactis MW98-8C to uracil auxotrophy. This au-
tonomously replicating sequence-containing vector, which is
unstable in K. lactis, was used to select for chromosomal inte-
gration of the expression cassette. One of the isolated Ura1
transformants, named MS1, expressed GUS activity over many
generations. Southern analysis revealed that integration of the
expression vector occurred at the chromosomal KlADH4 locus
by homologous recombination, which resulted in the duplica-
tion of the promoter region without interfering with the integ-
rity of the KlADH4 structural gene (data not shown). In fact, as
demonstrated in Fig. 2A, both genes are functionally expressed
and they are coregulated in an ethanol-dependent manner.
Furthermore, these results show that all elements relevant for
regulation are present on the 1.2-kb portable KlADH4 pro-
moter. Moreover, as shown by Northern analysis, GUS- and
KlADH4-specific transcripts can be detected as soon as 30 min
after induction by ethanol (Fig. 2B). For the GUS gene, be-
sides the mRNA of the expected length (about 2,300 nucleo-
tides), another, larger transcript which migrated at the level of
FIG. 1. (A) pKD1-derived expression vectors for K. lactis. pP4GUS harbours the replication origin (S11) of pKD1 and the b-glucuronidase (GUS) gene under the
control of the KlADH4 promoter. pYG132 and pYG156 contain the entire pKD1 sequence and the human serum albumin (HSA) gene under the control of the KlADH4
promoter. A, B, and C are pKD1 genes; IR1 and IR2 indicate the inverted repeats of the plasmid. b-Lactamase (bla) and aminoglycoside phosphotransferase (aph)
are the genes conferring ampicillin and geneticin (G418) resistance in bacterial and yeast cells, respectively. The uracil auxotrophic marker gene (URA3) and the
promoter regions of phosphoglycerate kinase (PGK) and killer toxin (KI) are also indicated. (B) 39 end sequences and cloning sites of the natural and engineered
promoters present in vectors pP4GUS, pYG132, and pYG156.
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the large rRNA was detected. This transcript, regulated in the
same way as the mature mRNA, could represent a precursor
molecule.
Production of HSA under control of the KlADH4 promoter
on multicopy vectors. Recently, increasing interest has been
focused on the production of HSA in K. lactis. The HSA cDNA
gene has been cloned into pKD1-derived vectors under the
control of the constitutive PGK promoter of S. cerevisiae and
the regulated LAC4 promoter of K. lactis, and good production
of the protein has been obtained under different growth con-
ditions (batch, fed batch, and chemostat) (5, 18).
To test whether the KlADH4 promoter could be efficiently
used for the biotechnological production of a protein of indus-
trial interest, we engineered vectors carrying the HSA cDNA
gene under the control of this promoter. In the first experi-
ment, we integrated the PKlADH4–prepro-HSA expression
cassette into the genome of K. lactis. Since the resulting inte-
grants showed very low levels of secreted HSA which could be
detected only by immunological methods (data not shown), we
examined the production of this protein in K. lactis strains
transformed with the pKD1-derived multicopy vector pYG132
(Fig. 1A), which carries 1.2 kbp of the KlADH4 promoter fused
to the HSA cDNA. This plasmid was introduced into the non-
fermenting strain CMK5, and after 3 days of growth in YP
medium containing different carbon sources, aliquots of super-
natants were analyzed for the presence of HSA by gel electro-
phoresis under denaturing conditions. The protein was re-
vealed either by Coomassie blue staining or by Western blot
analysis with an anti-HSA monoclonal antibody (Fig. 3A and
B). In CMK5, as in other nonfermenting strains, the HSA was
present only in the supernatant of cells grown in ethanol (lane
3) and not in the supernatant of glucose- or glycerol-grown
cells (lanes 2 and 4).
In these experiments, HSA expression levels were at least 30
to 40 times higher than those observed with the single-copy
integrant, which is in agreement with the average copy number
of pKD1-derived vectors (40 to 60 per cell). Interestingly, these
results indicate that even in the presence of multiple copies of
the KlADH4 promoter, there is no limitation of trans-acting
factors for the induction of the KlADH4 gene.
Identification of an ethanol-responsive element. To identify
possible cis-acting elements, we introduced deletions into the
KlADH4 promoter and parts of it were also cloned upstream of
the TATA box of the heterologous PGK promoter of S. cer-
evisiae. All constructions were introduced into CMK5 cells,
and the level of HSA produced by transformant clones was
analyzed by gel electrophoresis. The results of our analysis are
reported in Fig. 4. HSA production was not observed on eth-
anol with KlADH4 promoter deletions upstream of position
2536 (plasmids pYG534 and pYG397), suggesting that the
putative activating sequences were localized within the deleted
regions. On the other hand, we could observe ethanol-driven
expression of the HSA cDNA when the region from bp 21197
to 2536 was fused to the TATA box of both the KlADH4
(pCM13) and the PGK (pYG108/700M) genes. For this rea-
son, we performed a more detailed analysis of this region.
The most important results were obtained with plasmids
pCM15 and pYG108/2-4, which contained a region of about
200 bp spanning from 2953 to 2741 fused to the TATA box of
the KlADH4 and PGK genes, respectively. Both plasmids al-
lowed ethanol-dependent expression of the HSA cDNA. In
contrast, when this 200-bp region was missing (plasmid
pCM16), the regulatory property of the promoter was com-
pletely lost. No HSA production could be detected with the
control vector pYG108DUAS, which contained only the TATA
element of PGK.
To further confirm that the region from bp 2953 to 2741
contained the ethanol-responsive element(s), we substituted
this fragment to the upstream activation site (UAS) region of
the promoter of LAC4. This is the b-galactosidase-encoding
gene of K. lactis, which is induced by lactose and is repressed in
the presence of glucose (1, 26, 33, 38). The resulting hybrid
LAC4-KlADH4 promoter was fused to the HSA cDNA (plas-
mid pCM17), and the production of HSA on different carbon
sources was monitored. As shown in Fig. 4, this promoter could
drive HSA production only in ethanol-grown cells and, as ex-
pected, was no longer inducible by lactose (data not shown). In
control experiments (plasmid pYG107), the LAC4 promoter
fused to the HSA cDNA failed to drive HSA production on
glucose, glucose plus ethanol, and glycerol, whereas it allowed
HSA production in lactose-grown cells (not shown).
All the above results indicate that the element(s) necessary
and sufficient for the induction of KlADH4 by ethanol is lo-
cated within the 200-bp fragment spanning bp 2953 to 2741.
FIG. 2. Ethanol-dependent expression of KlADH4 and GUS genes. (A)
Strain MS1, carrying the GUS gene under the control of the KlADH4 promoter
integrated at the chromosomal KlADH4 locus, was grown overnight on 20 g of
glucose per liter (G, lane 1) and 20 g of ethanol per liter (Et, lane 2). The
presence in cellular extracts of the ADH IV and GUS activities were revealed by
specific staining on native acrylamide gels (see also Materials and Methods). (B)
Transcription analysis of KlADH4 and GUS genes after an overnight (O.N.)
growth on glucose and ethanol (lanes 1 and 2) and 15 to 60 min after the addition
of ethanol to glucose-grown cells (lanes 3 to 5). L and S indicate the migration
positions of the large and small rRNAs, respectively.
FIG. 3. pYG132-driven production of HSA with strain CMK5. Cells were
grown on 20 g of glucose per liter (G), 20 g of glucose per liter plus 10 g of
ethanol per liter (E), and 30 g of glycerol per liter (Gly) for three days. After
SDS-polyacrylamide gel electrophoresis of supernatants HSA was revealed by
Coomassie Blue staining (A) and by Western blotting with a monoclonal anti-
body, anti-HSA (B). Fifteen and 5 ml of supernatants were loaded in panels A
and B, respectively. Commercial HSA was loaded in lane 1 as a marker.
56 SALIOLA ET AL. APPL. ENVIRON. MICROBIOL.
This element, which also proved functional when inserted in
heterologous promoters, was named UASE.
pKlADH4-driven rHSA secretion in fed-batch fermenta-
tions. In shaken-flask cultures, the production of rHSA under
inducing conditions reached 200 to 250 mg/liter in defined
medium and 300 mg/liter in complex medium, which corre-
sponded to yields of 20 to 30 mg of rHSA/g of dry biomass.
These values represent 5 to 7% of the yeast total proteins and
80 to 90% of the total soluble proteins (data not shown).
To improve the rHSA yields, we performed fed-batch fer-
mentations (0.8 liter) on different media. In these experiments,
the vector used was pYG156, which carries the PGK gene for
selection (see Materials and Methods) and does not confer
resistance to the aminoglycoside antibiotic G418. After initial
batchwise growth of strain Y 721 in defined medium (DM1)
and consumption of the carbon substrate, the feed medium was
added to the fermentor by using a peristaltic pump coupled to
a preprogrammed time-based feeding profile, deduced from
previous experiments where the feeding rate was coupled to
the carbon dioxide evolution rate. The carbon substrate used
was a mixture of lactose and ethanol (final concentration, 20
g/liter) in different ratios: 50/50, 12/88, and 0/100.
As shown in Fig. 5A, when 100 g of carbon sources was
added, 45% of the carbon was recovered in the biomass when
100% ethanol was used, and this value increased to 53% when
lactose plus ethanol (12/88) was used. On the other side, the
best results in terms of rHSA production were obtained with
ethanol as the only carbon substrate (Fig. 5B). In fact, under
these conditions, about 800 mg of the protein per liter was
produced, compared to 200 and 350 mg/liter obtained when
different mixtures of ethanol and lactose were used. In conclu-
sion, at the end of the fermentation time (72 h) with ethanol as
the only carbon source, we obtained 71 g (dry-cell weight) of
biomass per liter with a yield (Yx/s) of 45%. At the same time,
620 mg of rHSA per liter was produced, with a yield (Yp/x) of
8.7 mg of rHSA/g of biomass and a productivity of 8.7 mg of
rHSA/liter z h.
Kinetics of rHSA secretion in fed-batch fermentations. The
growth and production kinetics of rHSA in complex medium
(ethanol, yeast extract, and ammonium acetate) and a defined
medium (ethanol, sodium glutamate, ammonium acetate, vita-
mins) have been compared. As shown in Fig. 6A and B, the
kinetics of growth and the production levels of rHSA were very
similar in the two media during the first 3 days, and we could
observe an increase in the specific productivity of rHSA from
5 to 30 mg/liter z h between 24 and 72 h of fermentation. After
4 days of culture, a high biomass production occurred in both
complex and defined media (70 and 80 g [dry-cell weight]/liter,
respectively), with a yield of about 45% as a result of the added
ethanol. In this period, the amount of rHSA produced was 1.05
g/liter in complex medium and 0.85 g/liter in defined medium,
which corresponded to a productivity of 15 and 10 mg of
rHSA/g of biomass, respectively. In both complex and defined
media, biomass and rHSA yields were well correlated with the
ethanol added during the fed-batch culture (Fig. 6C).
DISCUSSION
HSA is the most abundant protein in human plasma in-
volved in the maintenance of a normal osmolarity and also in
the transport of hydrophobic molecules. This protein has a big
market requirement in that it can be used as replacement fluid
during septic or traumatic shock, to compensate for blood loss,
and to treat burn victims. At present, HSA is largely produced
(300 tons/year) by conventional techniques involving fraction-
ation of plasma obtained from blood donors. It would be a
great advantage to be able to use genetic engineering to obtain
rHSA in good yield and at lower cost, with no danger of
contamination by human pathogens. For this reason, great
efforts have been dedicated to the production of this protein on
a large scale by genetically engineered microorganisms. For
this purpose, rHSA production has been studied in E. coli (24,
25) Bacillus subtilis (38), S. cerevisiae (11, 23, 31, 42, 43), Pichia
pastoris (30), and plants (41).
K. lactis is a very promising nonpathogenic organism because
of its good secretory capabilities (17, 18, 44, 46), and new
promoters with specific properties can be derived from this
yeast for the regulated expression of heterologous proteins. In
FIG. 4. HSA production with CMK5 cells carrying different regions of the KlADH4 promoter grown on 20 g of glucose per liter (G), 20 g of glucose plus 10 g of
ethanol per liter (E), and 30 g of glycerol per liter (Gly). Numbers, in approximate scale, refer to the KlADH4 promoter. HSA in supernatants was detected on
SDS-polyacrylamide gels followed by Coomassie Blue staining and quantified by comparison to known amounts of commercial HSA. All constructions were tested in
three independent fermentation experiments. 1 indicates HSA amounts similar to those observed with the entire KlADH4 promoter induced by ethanol; 2 indicates
undetectable HSA levels. , KlADH4 promoter; d, PGK promoter; , LAC4 promoter.
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fact, we isolated a new promoter from the KlADH4 gene of K.
lactis. This promoter, also present in multicopy vectors, allows
regulated or constitutive expression of heterologous genes de-
pending on the host strain used. In nonfermenting strains
(Rag2), which are unable to produce intracellular ethanol
from fermentable carbon sources, the transcriptional activa-
tion of the KlADH4 promoter is dependent on the addition of
ethanol to the culture medium. Nonfermenting K. lactis mu-
tants can be easily generated from fermenting strains with
particular industrially relevant properties (i.e., biomass yield
and secretion efficiency) by disrupting genes which affect eth-
anol production.
Another interesting aspect of the regulation of this promoter
is its insensitivity to glucose repression. This property, com-
bined with the specificity of ethanol as the activator, allows the
expression of cloned genes after the addition of the inducer,
independently of the carbon source present in the medium.
We identified an ethanol-responsive element (UASE) which
is located within a 200-bp region spanning from 2953 to 2741
of the promoter. Deletions of UASE render the KlADH4 pro-
moter no longer inducible in the presence of ethanol. On the
other hand, UASE constitutes an interesting “transportable”
cis-acting element for the construction of a regulated chimeric
promoter. In fact, UASE can confer ethanol-dependent pro-
moter activation, such as of the S. cerevisiae PGK and K. lactis
LAC4 promoters, which are usually not induced by this sub-
strate.
FIG. 5. Influence of carbon sources on biomass production (A) and rHSA
secretion (B) in fed-batch fermentation. K. lactis Y721 (pgk, Rag1), harboring
plasmid pYG156, was grown in defined medium containing 20 g of ethanol per
liter or mixtures of ethanol and lactose (final concentration, 20 g/liter) as the
carbon source. F, lactose-ethanol (50/50); n, lactose-ethanol (12/88); , lactose-
ethanol (0/100).
FIG. 6. Kinetics of rHSA secretion, biomass production, and ethanol con-
sumption in fed-batch cultures of K. lactis Y721 (pgk, Rag1) grown in complex
medium (A) and defined medium (B and C). F, ethanol; n, rHSA; , biomass.
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Finally, we studied the production of rHSA under the con-
trol of the KlADH4 promoter in K. lactis cells grown in complex
and defined media under different cultivation conditions. Con-
sidering the results obtained in terms of production per liter of
culture, high biomass production (70 to 80 g [dry-cell weight]/
liter) was obtained either in both complex and defined media,
and a significant amount of rHSA production was observed in
fed-batch cultures (1 g/liter) as compared to batch cultures (0.2
to 0.3 g/liter). These values are similar to those obtained under
the same conditions with the HSA gene under the control of
the PGK and LAC4 promoters (18).
On the basis of other studies, it should certainly be possible
to increase the level of production of rHSA to at least 2 g/liter
by working on the fermentation parameters. As an example,
under the culture conditions used, the oxygen uptake rate
never exceeded 2 mM/min.
In conclusion, we believe that the yields of rHSA obtained
can be improved and that the process can be scaled up.
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